![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1324, 2010-01, pp. : 25-25
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Antineoplastics/tacrolimus: Guillain-Barre syndrome?: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1213, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Influenza virus vaccine: Guillain-Barre syndrome: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1356, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levodopa/carbidopa: Abdominal pain: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1312, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Levodopa/carbidopa: Frégoli syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Efalizumab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :